Allspring Global Investments
ORKA

Allspring Global Investments’s Oruka Therapeutics ORKA Stock Holding History

Allspring Global Investments’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$357K Buy
+3,823
New +$255K ﹤0.01% 1539

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Allspring Global Investments's ORKA Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 3,823 shares worth $357K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings.

203 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Allspring Global Investments held 3,823 shares of Oruka Therapeutics worth $357K as of Q2 2026.
  • Oruka Therapeutics was a new Allspring Global Investments position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1539 holding.
  • 203 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.